Search
T-box transcription factor T
go.drugbank.com/bio_entities/BE0011656TargetHumansInvolved in the transcriptional regulation of genes required for mesoderm formation and differentiation. Binds to a palindromic T site 5'-TTCACACCTAGGTGTGAA-3' DNA sequence and activates gene transcription when bound to such a site
Polypeptides: T-box transcription factor TGentamicin
go.drugbank.com/drugs/DB00798ApprovedInvestigationalVet approvedGentamicin is a bactericidal aminoglycoside that was discovered and isolated from Micromonospora purpurea in 1963. It is one of the most frequently prescribed aminoglycosides due to its spectrum of activity, low cost, and availability. G...
Products: REFOBACIN BONE CEMENT RBone Giant Cell Tumor
go.drugbank.com/conditions/DBCOND0112909Drugs: DenosumabSynonyms: Bone giant cell tumour, Giant Cell Tumors of BoneBone Marrow Transplant Rejection
go.drugbank.com/conditions/DBCOND0030791Drugs: CyclosporineSynonyms: Rejection of bone marrow graft, Bone Marrow Transplant RejectionBone and Joint Infections
go.drugbank.com/conditions/DBCOND0051086Synonyms: Bone and joint infection, Bone and Joint InfectionsBone and tooth decay
go.drugbank.com/conditions/DBCOND0134714Drugs: Calcium gluconateSynonyms: Bone and tooth decayFluoride ion F-18
go.drugbank.com/drugs/DB09398ApprovedInvestigationalIts primary indication is for bone imaging. … Increased deposition around joints can occur in arthritis and following trauma and increased deposition in bone has been noted around fracture sites, in osteomyelitis, fibrous dysplasia, spondylitis tuberculosa
Synonyms: Fluoride ion F-18Mirvetuximab soravtansine
go.drugbank.com/drugs/DB12489ApprovedInvestigational[L43967,L43972] It was subsequently granted full approval in March 2024.[L50306] In October 2024, it was approved in the EU for the same indication. [L52640] … breast and non-small-cell lung cancers.
Burosumab
go.drugbank.com/drugs/DB14012ApprovedInvestigationalIt causes impaired bone growth and development in children and adolescents and issues with bone mineralization throughout a patient’s life [L2346]. … Most children with XLH suffer from bowed or bent legs, short stature, bone pain and severe dental pain.
Categories: Drugs for Treatment of Bone Diseases, Drugs Affecting Bone Structure and MineralizationAbaloparatide
go.drugbank.com/drugs/DB05084ApprovedInvestigational[A256778] Abaloparatide is an osteoanabolic agent that stimulates bone formation. … [L740] It was first approved by the FDA on April 28, 2017,[A256748] for the treatment of osteoporosis in postmenopausal women and is also used to increase bone density in men with osteoporosis.
Categories: Bone Density Conservation Agents